3D-Printed Piezoionic/Bioelectronic Hydrogel for Electro-Metabolic Regulation of Osteogenic Differentiation
Abstract
Bone regeneration is often hindered by large defects caused by trauma, tumors, or infection, necessitating advanced biomaterials beyond conventional grafts. Piezoelectric biomaterials have emerged as promising scaffolds due to their extracellular matrix-mimicking properties, with long-term conductivity offering additional advantages through electroactive interactions with cells. In this study, we present a direct ink writing 3D-printable, biodegradable, adhesive, and piezoionic-conductive nanocomposite hydrogel (GPMx) based on polypyrrole-grafted gelatin methacrylate (GelMA-PPy) and Ti3C2Tx (MXene) nanoflakes. The incorporation of MXene into the GelMA-PPy matrix enhanced the viscoelasticity, showcasing its excellent printability. The GPMx hydrogel demonstrates superior mechanical strength (∼450 ± 32.36 kPa), long-term conductivity (∼30.41 ± 3.21 S/cm), and strong adhesiveness (∼64.55 ± 13.17 kPa). Furthermore, the 3D-printed and dual-crosslinked GPMx-1% hydrogel functions as a piezoionic nanogenerator (PING), converting mechanical stress into electrical signals (∼8.29 ± 1.26 mV) upon varying strain. The macroporous PING hydrogel shows superior biocompatibility (>99%) with human bone mesenchymal stem cells (hBMSCs) and promotes osteogenic differentiation via bioelectric modulation. Additionally, antibody-functionalized GPMx enables label-free electrochemical sensing of alkaline phosphatase under various conditions (e.g., healthy or diseased), offering clinical potential for…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.